Angela Cramer

Absence of HER4 Expression Predicts Recurrence of Ductal Carcinoma <i>In situ</i> of the Breast

Nicola Barnes, Sahar Khavari, G.P. Boland et al. · Clinical Cancer Research · 2005 · 138 citations

Tumor Biology, Type 1, Breast Oncology +13

Molecular phenotypes of DCIS predict overall and invasive recurrence

Kathryn Williams, N L P Barnes, Angela Cramer et al. · Annals of Oncology · 2015 · 110 citations · Full text

Engineering, Medicine, Pathogenesis +7

Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for <i>BRCA1</i> and <i>BRCA2</i> testing

D. Gareth Evans, Fiona Lalloo, Angela Cramer et al. · Journal of Medical Genetics · 2009 · 95 citations · Full text

Insights from Studies with Oral Cleft Genes Suggest Associations between WNT-pathway Genes and Risk of Oral Cancer

Pedro A. Andrade Filho, Ariadne Letra, Angela Cramer et al. · Journal of Dental Research · 2011 · 90 citations

Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity

G. Wilson, Angela Cramer, Arkadiusz Welman et al. · British Journal of Cancer · 2006 · 74 citations · Full text